- Home
- ACGLN vs FBIOP Comparison
ACGLN vs FBIOP Comparison
Compare ACGLN & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACGLN
- FBIOP
- Stock Information
- Founded
- ACGLN N/A
- FBIOP N/A
- Country
- ACGLN Bermuda
- FBIOP United States
- Employees
- ACGLN 5800
- FBIOP 186
- Industry
- ACGLN Property-Casualty Insurers
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- ACGLN Finance
- FBIOP Health Care
- Exchange
- ACGLN Nasdaq
- FBIOP Nasdaq
- Market Cap
- ACGLN N/A
- FBIOP N/A
- IPO Year
- ACGLN N/A
- FBIOP N/A
- Fundamental
- Price
- ACGLN $20.67
- FBIOP $5.60
- Analyst Decision
- ACGLN
- FBIOP
- Analyst Count
- ACGLN 0
- FBIOP 0
- Target Price
- ACGLN N/A
- FBIOP N/A
- AVG Volume (30 Days)
- ACGLN N/A
- FBIOP N/A
- Earning Date
- ACGLN N/A
- FBIOP N/A
- Dividend Yield
- ACGLN N/A
- FBIOP N/A
- EPS Growth
- ACGLN N/A
- FBIOP N/A
- EPS
- ACGLN N/A
- FBIOP N/A
- Revenue
- ACGLN N/A
- FBIOP N/A
- Revenue This Year
- ACGLN N/A
- FBIOP N/A
- Revenue Next Year
- ACGLN N/A
- FBIOP N/A
- P/E Ratio
- ACGLN N/A
- FBIOP N/A
- Revenue Growth
- ACGLN N/A
- FBIOP N/A
- 52 Week Low
- ACGLN N/A
- FBIOP N/A
- 52 Week High
- ACGLN N/A
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- ACGLN 56.46
- FBIOP 53.17
- Support Level
- ACGLN $20.31
- FBIOP $5.06
- Resistance Level
- ACGLN $20.72
- FBIOP $5.32
- Average True Range (ATR)
- ACGLN 0.24
- FBIOP 0.23
- MACD
- ACGLN -0.01
- FBIOP 0.10
- Stochastic Oscillator
- ACGLN 83.61
- FBIOP 66.67
About ACGLN Arch Capital Group Ltd.
Arch Capital Group Ltd is a Bermuda company which writes insurance and reinsurance with operations in Bermuda, the United States, Canada, Europe, Australia and United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage two operating segments: corporate and other. The insurance segment provides specialty risk solutions to client across a variety of industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.